🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Kidney Transplant Infection

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft NCT04989491Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Rituximab, control group A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation NCT06243731n/a25 sites📍 Anderlecht📍 Leuven📍 Tallinn Takeda · Tests: No Intervention Double Voiding and Post-transplant UTI NCT05711446NA1 site📍 New York Weill Medical College of Cornell University · Tests: Double Voiding, Regular Voiding Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure NCT06881927Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Hydrocortisone Hemisuccinate: 200 mg per day., reduction of the level of immunosuppression Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) NCT06341543NA1 site📍 Grenoble University Hospital, Grenoble · Tests: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the … Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients NCT06407232Phase 31 site📍 Madison University of Wisconsin, Madison · Tests: Letermovir Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors NCT07368153Phase 24 sites📍 Bern📍 Zurich📍 Lausanne University Hospital, Basel, Switzerland · Tests: indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, placebo Tacrolimus Pharmacokinetic Subpopulations NCT04526431n/a2 sites📍 Grenoble📍 Saint-Etienne University Hospital, Grenoble · Tests: Dosage Forms Oral Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study NCT07294547NA1 site📍 Taipei National Taiwan University Hospital · Tests: Valacyclovir (Valtrex), Valganciclovir (Valcyte) Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients NCT06409819Phase 1, Phase 21 site📍 La Jolla University of California, San Diego · Tests: phage therapy, control A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients NCT05325008Phase 313 sites📍 Canberra📍 New Lambton Heights📍 Randwick The University of Queensland · Tests: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial. NCT05597540Phase 39 sites📍 Bordeaux📍 Boulogne-Billancourt📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Short antibiotic treatment, Usual antibiotic treatment Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients NCT05708508Phase 31 site📍 Rouen University Hospital, Rouen · Tests: ROVALCYTE A Trial to Evaluate the Safety, Tolerability and Efficacy of AIC263029 in Kidney Transplant Recipients With BKV Infection NCT07503561Phase 27 sites📍 Birmingham📍 Tampa📍 Atlanta AiCuris Anti-infective Cures AG · Tests: AIC263029, Placebo Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients NCT07266467Phase 41 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Letermovir, Valganciclovir SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study NCT04494776n/a1 site📍 São Paulo Helio Tedesco Silva Junior Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors NCT05159466n/a1 site📍 Metairie Tulane University · Tests: Kidney transplant Shingrix in Renal Transplant Recipients NCT04128189Phase 34 sites📍 Aurora📍 Atlanta📍 Boston University of Colorado, Denver · Tests: Shingrix Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation NCT01515605n/a1 site📍 Odense Odense University Hospital Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) NCT06263426NA18 sites📍 Birmingham📍 Sacramento📍 San Diego Johns Hopkins University · Tests: HIV D+/R+, HIV D-/R+ The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study NCT05588492Phase 41 site📍 Taipei National Taiwan University Hospital · Tests: Rifamycin-containing regimen, Rifamycin-free regimen Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients NCT07197164Phase 21 site📍 Badalona Fundación FLS de Lucha Contra el Sida, las Enfermedades Inf… · Tests: Remdesivir (RDV) Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site📍 Chicago Northwestern University Immune Registry for BK in Kidney Transplant Recipients NCT06538961n/a1 site📍 Richmond Virginia Commonwealth University · Tests: Blood samples: Main Study group, Data Collection, Urine Sample- Main Study group, Urine sample- Sub-study group, Blood … Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections NCT06334497Phase 35 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Letermovir, Valganciclovir, Letermovir placebo TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719NA4 sites📍 Bordeaux (France)📍 Lyon📍 Strasbourg (france) Hospices Civils de Lyon · Tests: TTV DNAemia, EQ-5D-5L questionnaire, Biological tests A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant NCT04006808Phase 1, Phase 231 sites📍 Brussels📍 Ghent📍 Leuven GlaxoSmithKline · Tests: PED-HZ/su A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites📍 Duarte📍 La Jolla📍 Loma Linda Pierre Fabre Medicament · Tests: tabelecleucel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy